azathioprine has been researched along with Exocrine Pancreatic Insufficiency in 5 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Exocrine Pancreatic Insufficiency: A malabsorption condition resulting from greater than 10% reduction in the secretion of pancreatic digestive enzymes (LIPASE; PROTEASES; and AMYLASE) by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our cases demonstrate resemblances with autoimmune pancreatitis based on clinical and imaging findings." | 3.01 | Immune Checkpoint Inhibitor-related Pancreatitis: A Case Series, Review of the Literature and an Expert Opinion. ( Blokzijl, H; Kramer, S; van der Heide, F; van Hee, K; Visschedijk, MC, 2023) |
| "However, disease relapse is common in long-term follow-up, despite a successful initial treatment response." | 1.48 | Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment. ( Cho, DH; Jun, JH; Kim, MH; Lee, HW; Lee, SK; Lee, SS; Moon, SH; Nam, K; Park, DH; Seo, DW; Song, TJ, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kramer, S | 1 |
| van Hee, K | 1 |
| Blokzijl, H | 1 |
| van der Heide, F | 1 |
| Visschedijk, MC | 1 |
| Lee, HW | 1 |
| Moon, SH | 1 |
| Kim, MH | 1 |
| Cho, DH | 1 |
| Jun, JH | 1 |
| Nam, K | 1 |
| Song, TJ | 1 |
| Park, DH | 1 |
| Lee, SS | 1 |
| Seo, DW | 1 |
| Lee, SK | 1 |
| Rodríguez-Alarcón, CA | 1 |
| Beristaín-Ruiz, DM | 1 |
| Pérez-Casio, F | 1 |
| Rivera, R | 1 |
| Ochoa, G | 1 |
| Martín-Orozco, U | 1 |
| Wiberg, ME | 1 |
| Westermarck, E | 1 |
| Sifianou, P | 1 |
| Tsoka, H | 1 |
| Kitra, V | 1 |
| Haidas, S | 1 |
| Pantelakis, S | 1 |
1 review available for azathioprine and Exocrine Pancreatic Insufficiency
| Article | Year |
|---|---|
Immune Checkpoint Inhibitor-related Pancreatitis: A Case Series, Review of the Literature and an Expert Opinion.
Topics: Autoimmune Pancreatitis; Azathioprine; Exocrine Pancreatic Insufficiency; Expert Testimony; Humans; | 2023 |
1 trial available for azathioprine and Exocrine Pancreatic Insufficiency
| Article | Year |
|---|---|
Subclinical exocrine pancreatic insufficiency in dogs.
Topics: Animals; Azathioprine; Dietary Supplements; Disease Progression; Dog Diseases; Dogs; Enzyme Therapy; | 2002 |
3 other studies available for azathioprine and Exocrine Pancreatic Insufficiency
| Article | Year |
|---|---|
Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Topics: Aged; Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Bile Duct Diseases; Calculi; Exoc | 2018 |
Protein-losing enteropathy in a dog with lymphangiectasia, lymphoplasmacytic enteritis and pancreatic exocrine insufficiency.
Topics: Animals; Azathioprine; Biopsy; Combined Modality Therapy; Diet; Dog Diseases; Dogs; Endoscopy; Exocr | 2012 |
Diabetes mellitus and exocrine pancreatic insufficiency in a girl with auto-immune haemolysis.
Topics: Anemia, Hemolytic, Autoimmune; Azathioprine; Diabetes Mellitus; Drug Synergism; Exocrine Pancreatic | 1992 |